MARSTACIMAB (mar STAK i mab) prevents bleeding episodes in people with hemophilia, a condition caused by low levels of blood clotting factors. It works by helping your body make a protein that helps your blood clot. This lowers the risk of bleeding. It is a monoclonal antibody.


There is no lifestyle interaction information available for this medication.